
Erasca Investors Face Lead Plaintiff Deadline in Securities Fraud Suit
Investors who incurred financial losses holding Erasca, Inc. stock between January 2025 and April 2026 have until August 10 to step forward as lead plaintiffs. The class action lawsuit claims the biotechnology company misled shareholders regarding the integrity of its preclinical data for the drug candidate ERAS-0015.






.jpg)




















